MENU

CSBR Champions Oncology Forecast, Technical & Fundamental Analysis

a provider of advanced technology solutions and services for oncology drugs

Industry Biotechnology
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published Earnings

CSBR is expected to report earnings to fall 1,100.00% to -10 cents per share on September 06

Champions Oncology CSBR Stock Earnings Reports
Q3'24
Est.
$-0.10
Q2'24
Beat
by $0.17
Q1'24
Missed
by $0.10
Q4'23
Beat
by $0.01
Q3'23
Missed
by $0.03
The last earnings report on July 18 showed earnings per share of 0 cents, beating the estimate of -15 cents. With 41.61K shares outstanding, the current market capitalization sits at 64.16M.
A.I. Advisor
published General Information

General Information

a provider of advanced technology solutions and services for oncology drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One University Plaza
Phone
+1 201 808-8400
Employees
230
Web
https://www.championsoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

CSBR and Stocks

Correlation & Price change

A.I.dvisor tells us that CSBR and LIXT have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBR and LIXT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSBR
1D Price
Change %
CSBR100%
-1.54%
LIXT - CSBR
25%
Poorly correlated
+2.81%
PMN - CSBR
23%
Poorly correlated
-4.11%
ABOS - CSBR
22%
Poorly correlated
-10.58%
LBPH - CSBR
22%
Poorly correlated
-5.74%
LPTX - CSBR
21%
Poorly correlated
-1.38%
More

Groups containing CSBR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSBR
1D Price
Change %
CSBR100%
-1.54%
drugs
theme (265 stocks)
-0%
Poorly correlated
+5.37%
oncology
theme (18 stocks)
-1%
Poorly correlated
+0.37%
biotechnology
theme (248 stocks)
-1%
Poorly correlated
+5.56%
cancer
theme (87 stocks)
-3%
Poorly correlated
+0.89%
technology
theme (33 stocks)
-4%
Poorly correlated
+0.06%